National Saudi Consensus Statement on the Management of Atopic Dermatitis (2021)

被引:5
作者
Fatani, Mohammad I. [1 ]
Al Sheikh, Afaf A. [2 ,3 ]
Alajlan, Mohammed A. [4 ]
Alharithy, Ruaa S. [5 ,6 ]
Binamer, Yousef [7 ,8 ]
Albarakati, Rayan G. [9 ]
Alenzi, Khalidah A. [10 ]
Khardaly, Amr M. [11 ]
Alomari, Bedor A. [12 ]
Almudaiheem, Hajer Y. [11 ]
Al-Jedai, Ahmed [11 ]
Eshmawi, Maysa T. [13 ]
机构
[1] Minist Hlth, Hera Gen Hosp, Mecca, Saudi Arabia
[2] King Saud Bin Abdulaziz Univ Hlth Sci, Riyadh, Saudi Arabia
[3] King Abdulaziz Med City Natl Guard Hlth Affairs, Riyadh, Saudi Arabia
[4] King Fahad Med City, Riyadh, Saudi Arabia
[5] Princess Nourah Bint Abdul Rahman Univ, Riyadh, Saudi Arabia
[6] Secur Forces Hosp, Riyadh, Saudi Arabia
[7] King Faisal Specialist Hosp & Res Ctr, Riyadh, Saudi Arabia
[8] Alfaisal Univ, Riyadh, Saudi Arabia
[9] Majmaah Univ, Al Majmaah 11952, Saudi Arabia
[10] Minist Hlth, Reg Drug Informat & Pharmacovigilance Ctr, Tabuk, Saudi Arabia
[11] Minist Hlth, Therapeut Affairs, Riyadh, Saudi Arabia
[12] Prince Sultan Mil Med City, Riyadh, Saudi Arabia
[13] King Abdullah Med Complex, Prince Nayef St, Jeddah 23816, Saudi Arabia
关键词
Consensus; Atopic dermatitis; Saudi Arabia; TACROLIMUS OINTMENT; POSITION PAPER; DOUBLE-BLIND; TASK-FORCE; EUROPEAN GUIDELINES; TOPICAL TREATMENT; ADULT PATIENTS; ECZEMA; CHILDREN; EFFICACY;
D O I
10.1007/s13555-022-00762-6
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Atopic dermatitis (AD) is a chronic inflammatory skin disease with an increasing prevalence regionally and globally. It is characterized by intense itching and recurrent eczematous lesions. With the increase in the availability of treatment options for healthcare practitioner and patients, new challenges arise for treatment selection and approach. The current consensus statement has been developed to provide up-to-date evidence and evidence-based recommendations to guide dermatologists and healthcare professionals managing patients with AD in Saudi Arabia. By an initiative from the Ministry of Health (MOH), a multidisciplinary work group of 11 experts was convened to review and discuss aspects of AD management. Four consensus meetings were held on January 14, February 4, February 25, and March 18 of 2021. All consensus content was voted on by the work group, including diagnostic criteria, AD severity assessment, comorbidities, and therapeutic options for AD. Special consideration for the pediatric population, as well as women during pregnancy and lactation, was also discussed. The present consensus document will be updated as needed to incorporate new data or therapeutic agents.
引用
收藏
页码:1551 / 1575
页数:25
相关论文
共 118 条
[1]   Extended implementation of educational programs for atopic dermatitis in childhood [J].
Ahrens, Birgit ;
Staab, Doris .
PEDIATRIC ALLERGY AND IMMUNOLOGY, 2015, 26 (03) :190-196
[2]   Atopy and allergic diseases among Saudi young adults: A cross-sectional study [J].
Alqahtani, Jobran Miree .
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2020, 48 (01)
[3]  
[Anonymous], 2011, PRODUCT INFORM PROTO
[4]  
[Anonymous], 2006, PRODUCT INFORM ELIDE
[5]  
[Anonymous], 2020, PRODUCT INFORM DUPIX
[6]  
[Anonymous], 2020, PRODUCT INFORM EUCRI
[7]   Epidemiology of atopic dermatitis in adults: Results from an international survey [J].
Barbarot, S. ;
Auziere, S. ;
Gadkari, A. ;
Girolomoni, G. ;
Puig, L. ;
Simpson, E. L. ;
Margolis, D. J. ;
de Bruin-Weller, M. ;
Eckert, L. .
ALLERGY, 2018, 73 (06) :1284-1293
[8]   Atopic Dermatitis and Respiratory Allergy: What is the Link [J].
Belgrave D.C.M. ;
Simpson A. ;
Buchan I.E. ;
Custovic A. .
Current Dermatology Reports, 2015, 4 (4) :221-227
[9]  
Berke R, 2012, AM FAM PHYSICIAN, V86, P35
[10]   Azathioprine in severe adult atopic dermatitis: a double-blind, placebo-controlled, crossover trial [J].
Berth-Jones, J ;
Takwale, A ;
Tan, E ;
Barclay, G ;
Agarwal, S ;
Ahmed, I ;
Hotchkiss, K ;
Graham-Brown, RAC .
BRITISH JOURNAL OF DERMATOLOGY, 2002, 147 (02) :324-330